Author

Marios Lazanas

Observed names: M Lazanas, M. Lazanas, M.C. Lazanas

Institutions: Hellenic Red Cross, Red Cross Hospital, IASO General Hospital

Observed institutions: National and Kapodistrian University of Athens, Hellenic Red Cross, Red Cross Hospital, Tzaneion General Hospital, National Cancer Institute, IASO General Hospital, Hôpital Bichat-Claude-Bernard

ORCID: 0000-0002-9638-0321

Observed ORCIDs: 0000-0002-9638-0321, 0000-0002-3068-105X

OpenAlex ID: A5067396896

Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy

2002 · Antonio Valentin, Margherita Rosati, et al. · Proceedings of the National Academy of Sciences · 174

HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report

2011 · D Paraskevis, G Nikolopoulos, et al. · Eurosurveillance · 118

PDF

Economic Recession and Emergence of an HIV-1 Outbreak among Drug Injectors in Athens Metropolitan Area: A Longitudinal Study

2013 · Dimitrios Paraskevis, Georgios Nikolopoulos, et al. · PLoS ONE · 115

PDF

Prevalence study of hospital-acquired infections in 14 Greek hospitals: planning from the local to the national surveillance level

2002 · A. Gikas, J. Pediaditis, et al. · Journal of Hospital Infection · 84

Low-Dose IFN- α Monotherapy in Treatment-Naive Individuals with HIV-1 Infection: Evidence of Potent Suppression of Viral Replication

2001 · Angelos Hatzakis, Panagiotis Gargalianos, et al. · Journal of Interferon & Cytokine Research · 49

Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays—LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5

2005 · Antigoni Katsoulidou, Maria Petrodaskalaki, et al. · Journal of Virological Methods · 42

Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003–2015: Transmitted drug resistance is due to onward transmissions

2017 · D. Paraskevis, E. Kostaki, et al. · Infection Genetics and Evolution · 33

Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma

2001 · Cleo G Anastassopoulou, Giota Touloumi, et al. · Journal of Virological Methods · 19

Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock‐inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors

2022 · Evangelia Georgia Kostaki, Stefanos Limnaios, et al. · HIV Medicine · 17

PDF

PAF of biological fluids in disease: blood levels in allergic rhinitis.

1988 · K Labrakis-Lazanas, M Lazanas, et al. · PubMed · 15

In Vivo Effects of a Ginkgo Biloba Extract on Platelet Activating Factor Metabolism in Two Asymptomatic Hiv-Infected Patients

2011 · A.B. Tsoupras, M. Chini, et al. · European Journal of Inflammation · 12

PDF

Comparison of three current viral load assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma

2004 · Antigoni Katsoulidou, Eleni Papachristou, et al. · Journal of Virological Methods · 12

Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients

1999 · Emmanuil Magiorkinis, Dimitrios Paraskevis, et al. · AIDS · 8

Selective transmission of drug resistance mutations

2005 · David van de Vijver, Amj Wensing, et al. · Antiviral Therapy · 6

Dating the Origin and Estimating the Transmission Rates of the Major HIV-1 Clusters in Greece: Evidence about the Earliest Subtype A1 Epidemic in Europe

2022 · Stefanos Limnaios, Evangelia Georgia Kostaki, et al. · Viruses · 4

PDF

Enteroviral Infection in Greek AIDS Patients

2004 · Dimitrios Papaventsis, Panayotis Markoulatos, et al. · Molecular Diagnosis · 4

[Neuromeningeal Listeria infections in adults. Clinical, biological and therapeutic aspects. Apropos of 36 cases].

1991 · M Lazanas, C Perronne, et al. · PubMed · 4

Body composition in asymptomatic HIV-infected men: cross-sectional and prospective assessment

2003 · Marios Lazanas, Irene Lambrinoudaki, et al. · HORMONES · 3

PDF

Patterns of drug resistance among newly diagnosed HIV‐1 infected patients in Greece during the last decade: the crucial role of transmission networks

2014 · Dimitrios Paraskevis, Assimina Zavitsanou, et al. · Journal of the International AIDS Society · 1

Incidence and risk factors of chronic renal disease in a cohort of Greek HIV‐1‐infected adults

2012 · V Sakka, G Bakoyannis, et al. · Journal of the International AIDS Society · 1

Tracing the patterns of HIV-1 transmission among people with different diagnosis status in Greece

2026 · Evangelia Georgia Kostaki, Stefanos Limnaios, et al. · Virus Research

PDF

2026 · Charalampos D. Moschopoulos, Nikos Pantazis, et al. · HIV Medicine

PDF

Endocrine disorders in treatment-naive male patients with HIV infection

2017 · Nikolaos Kalogeris, Markella Nezi, et al. · Endocrine Abstracts

Budget impact analysis of switch to darunavir/ritonavir monotherapy in Greece

2012 · M Lazanas, A Hill, et al. · Journal of the International AIDS Society

PDF

Prevalence of Peripheral Arterial Disease in an HIV-Infected Population

2009 · Marios Lazanas · 47th Annual Meeting

Works count: 26

Citation count: 721

H-index: 12

I10-index: 12